Literature DB >> 16214351

3D-QSAR study of ring-substituted quinoline class of anti-tuberculosis agents.

Amit Nayyar1, Alpeshkumar Malde, Rahul Jain, Evans Coutinho.   

Abstract

A 3D-QSAR analysis of a new class of ring-substituted quinolines with anti-tuberculosis activity has been carried out by three methods-Comparative Molecular Field Analysis (CoMFA), CoMFA with inclusion of a hydropathy field (HINT), and Comparative Molecular Similarity Indices Analysis (CoMSIA). The conformation of the molecules was generated using a simulated annealing protocol and they were superimposed using features common to the set with database alignment (SYBYL) and field fit methods. Several statistically significant CoMFA, CoMFA with HINT, and CoMSIA models were generated. Prediction of the activity of a set of test molecules was the best for the CoMFA model generated with database alignment. Based upon the information contained in the CoMFA model, we have identified some novel features that can be incorporated into the quinoline framework to improve the activity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16214351     DOI: 10.1016/j.bmc.2005.09.018

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  10 in total

1.  3D-QSAR studies of Dipeptidyl peptidase IV inhibitors using a docking based alignment.

Authors:  Raghuvir R S Pissurlenkar; Mushtaque S Shaikh; Evans C Coutinho
Journal:  J Mol Model       Date:  2007-08-04       Impact factor: 1.810

2.  Effect of steric molecular field settings on CoMFA predictivity.

Authors:  Ruchi R Mittal; Ross A McKinnon; Michael J Sorich
Journal:  J Mol Model       Date:  2007-11-24       Impact factor: 1.810

3.  Molecular docking and 3D-QSAR studies of HIV-1 protease inhibitors.

Authors:  Vijay M Khedkar; Premlata K Ambre; Jitender Verma; Mushtaque S Shaikh; Raghuvir R S Pissurlenkar; Evans C Coutinho
Journal:  J Mol Model       Date:  2010-01-13       Impact factor: 1.810

4.  High-throughput screening for inhibitors of Mycobacterium tuberculosis H37Rv.

Authors:  Subramaniam Ananthan; Ellen R Faaleolea; Robert C Goldman; Judith V Hobrath; Cecil D Kwong; Barbara E Laughon; Joseph A Maddry; Alka Mehta; Lynn Rasmussen; Robert C Reynolds; John A Secrist; Nice Shindo; Dustin N Showe; Melinda I Sosa; William J Suling; E Lucile White
Journal:  Tuberculosis (Edinb)       Date:  2009-09-15       Impact factor: 3.131

Review 5.  Computational databases, pathway and cheminformatics tools for tuberculosis drug discovery.

Authors:  Sean Ekins; Joel S Freundlich; Inhee Choi; Malabika Sarker; Carolyn Talcott
Journal:  Trends Microbiol       Date:  2010-12-02       Impact factor: 17.079

6.  www.3d-qsar.com: a web portal that brings 3-D QSAR to all electronic devices-the Py-CoMFA web application as tool to build models from pre-aligned datasets.

Authors:  Rino Ragno
Journal:  J Comput Aided Mol Des       Date:  2019-10-08       Impact factor: 3.686

7.  QSAR-driven design, synthesis and discovery of potent chalcone derivatives with antitubercular activity.

Authors:  Marcelo N Gomes; Rodolpho C Braga; Edyta M Grzelak; Bruno J Neves; Eugene Muratov; Rui Ma; Larry L Klein; Sanghyun Cho; Guilherme R Oliveira; Scott G Franzblau; Carolina Horta Andrade
Journal:  Eur J Med Chem       Date:  2017-05-10       Impact factor: 6.514

8.  General electrochemical Minisci alkylation of N-heteroarenes with alkyl halides.

Authors:  Roberto Del Río-Rodríguez; Lorena Fragoso-Jarillo; Alberto F Garrido-Castro; M Carmen Maestro; Jose A Fernández-Salas; José Alemán
Journal:  Chem Sci       Date:  2022-05-06       Impact factor: 9.969

Review 9.  Hydrophobicity--shake flasks, protein folding and drug discovery.

Authors:  Aurijit Sarkar; Glen E Kellogg
Journal:  Curr Top Med Chem       Date:  2010       Impact factor: 3.295

10.  Molecular modeling studies, synthesis, and biological evaluation of Plasmodium falciparum enoyl-acyl carrier protein reductase (PfENR) inhibitors.

Authors:  Varun A Morde; Mushtaque S Shaikh; Raghuvir R S Pissurlenkar; Evans C Coutinho
Journal:  Mol Divers       Date:  2009-04-04       Impact factor: 2.943

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.